{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:33:12Z","timestamp":1786494792339,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100979 R01NS110596 R03NS114623"],"award-info":[{"award-number":["R01NS100979 R01NS110596 R03NS114623"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Dementia and autoimmune diseases are prevalent conditions with limited treatment options. Taurine and homotaurine (HT) are naturally occurring sulfonate amino acids, with taurine being highly abundant in animal tissues, but declining with age in the blood. HT is a blood-brain barrier permeable drug under investigation for Alzheimer\u2019s disease. HT also has beneficial effects in a mouse model of multiple sclerosis likely through an anti-inflammatory mechanism mediated by GABA<jats:sub>A<\/jats:sub> receptor (GABA<jats:sub>A<\/jats:sub>R) agonism in immune cells. While both taurine and HT are structural GABA analogs and thought to be GABA mimetics at GABA<jats:sub>A<\/jats:sub>Rs, there is uncertainty concerning their potency as GABA mimetics on native GABA<jats:sub>A<\/jats:sub>Rs. We show that HT is a very potent GABA mimetic, as it evokes GABA<jats:sub>A<\/jats:sub>R-mediated currents with an EC<jats:sub>50<\/jats:sub> of 0.4\u00a0\u03bcM (vs. 3.7\u00a0\u03bcM for GABA and 116\u00a0\u00b5M for taurine) in murine cerebellar granule cells in brain slices, with both taurine and HT having similar efficacy in activating native GABA<jats:sub>A<\/jats:sub>Rs. Furthermore, HT displaces the high affinity GABA<jats:sub>A<\/jats:sub>R ligand [<jats:sup>3<\/jats:sup>H]muscimol at similarly low concentrations (HT IC<jats:sub>50<\/jats:sub> of 0.16\u00a0\u03bcM vs. 125\u00a0\u03bcM for taurine) in mouse brain homogenates. The potency of taurine and HT as GABA<jats:sub>A<\/jats:sub>R agonists aligns with endogenous concentrations of taurine in the blood and with HT concentrations achieved in the brain following oral administration of HT or the HT pro-drug ALZ-801. Consequently, we discuss that GABA<jats:sub>A<\/jats:sub>Rs subtypes, similar to the ones we studied here in neurons, are plausible targets for mediating the potential beneficial effects of taurine in health and life-span extension and the beneficial HT effects in dementia and autoimmune conditions.<\/jats:p>","DOI":"10.3389\/fphar.2023.1271203","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:24:18Z","timestamp":1702574658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions"],"prefix":"10.3389","volume":"14","author":[{"given":"Pratap","family":"Meera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Uusi-Oukari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Lipshutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s11064-005-8986-6","article-title":"Taurine interaction with neurotransmitter receptors in the CNS: an update","volume":"30","author":"Albrecht","year":"2005","journal-title":"Neurochem. Res."},{"key":"B2","first-page":"497","article-title":"gamma-Aminobutyric acid agonists and antagonists alter chloride flux across brain membranes","volume":"29","author":"Allan","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41467-020-15855-z","article-title":"Ethanol consumption inhibits T-FH cell responses and the development of autoimmune arthritis","volume":"11","author":"Azizov","year":"2020","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","article-title":"GABAergic signaling by cells of the immune system: more the rule than the exception","volume":"78","author":"Bhandage","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABAA receptor channels from low-to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0922-4106(05)80031-8","article-title":"Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro","volume":"207","author":"Bureau","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3949\/ccjm.83a.15050","article-title":"Taurine, energy drinks, and neuroendocrine effects","volume":"83","author":"Caine","year":"2016","journal-title":"Clevel. Clin. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1523\/JNEUROSCI.0897-16.2016","article-title":"Rescue of the functional alterations of motor cortical circuits in arginase deficiency by neonatal gene therapy","volume":"36","author":"Cantero","year":"2016","journal-title":"J. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"611841","DOI":"10.3389\/fncir.2020.611841","article-title":"Origins, development, and compartmentation of the granule cells of the cerebellum","volume":"14","author":"Consalez","year":"2021","journal-title":"Front. Neural Circuits"},{"key":"B10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell."},{"key":"B14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","article-title":"Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of tramiprosate in development for the treatment of alzheimer's disease","volume":"57","author":"Hey","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","article-title":"Physiological actions of taurine","volume":"72","author":"Huxtable","year":"1992","journal-title":"Physiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1523\/JNEUROSCI.3996-07.2008","article-title":"Taurine is a potent activator of extrasynaptic GABAA receptors in the thalamus","volume":"28","author":"Jia","year":"2008","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcp.12070","article-title":"The clinical pharmacology of acamprosate","volume":"77","author":"Kalk","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1113\/jphysiol.1995.sp020739","article-title":"Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum","volume":"485","author":"Kaneda","year":"1995","journal-title":"J. Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s42255-022-00638-1","article-title":"GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation","volume":"4","author":"Kang","year":"2022","journal-title":"Nat. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/scientificamerican0203-74","article-title":"Drink to your health?","volume":"288","author":"Klatsky","year":"2003","journal-title":"Sci. Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","article-title":"Elucidating the A\u03b242 anti-aggregation mechanism of action of tramiprosate in alzheimer's disease: integrating molecular analytical methods, pharmacokinetic and clinical data","volume":"31","author":"Kocis","year":"2017","journal-title":"Cns Drugs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-210607","article-title":"Potential mechanisms underlying resistance to dementia in non-demented individuals with alzheimer's disease neuropathology","volume":"87","author":"Kok","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0006-8993(86)91230-8","article-title":"In vivo determination of extracellular concentration of amino-acids in the rat Hippocampus - a method based on brain dialysis and computerized analysis","volume":"384","author":"Lerma","year":"1986","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1096\/fj.03-0739com","article-title":"Taurine prevents the neurotoxicity of \u03b2-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders","volume":"18","author":"Louzada","year":"2004","journal-title":"Faseb J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fneur.2020.00614","article-title":"A review on tramiprosate (homotaurine) in alzheimer's disease and other neurocognitive disorders","volume":"11","author":"Manzano","year":"2020","journal-title":"Front. Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuropharm.2008.08.011","article-title":"Etomidate, propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant \u03b14\u03b23\u03b4 and \u03b14\u03b23 GABAA receptors expressed in HEK cells","volume":"56","author":"Meera","year":"2009","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jnc.15774","article-title":"Guanidinoacetate (GAA) is a potent GABAA receptor GABA mimetic: implications for neurological disease pathology","volume":"165","author":"Meera","year":"2023","journal-title":"J. Neurochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1152\/jn.00450.2011","article-title":"Molecular basis for the high THIP\/gaboxadol sensitivity of extrasynaptic GABAA receptors","volume":"106","author":"Meera","year":"2011","journal-title":"J. Neurophysiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12868-018-0448-6","article-title":"Differential modulation of human GABAC-\u03c11 receptor by sulfur-containing compounds structurally related to taurine","volume":"19","author":"Ochoa-de la Paz","year":"2018","journal-title":"BMC Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.eplepsyres.2013.01.010","article-title":"Taurine and epilepsy","volume":"104","author":"Oja","year":"2013","journal-title":"Epilepsy Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0006-8993(81)90538-2","article-title":"Inhibitory actions of taurocyamine, hypotaurine, homotaurine, taurine and GABA on spike discharges of purkinje-cells, and localization of sensitive sites, in Guinea-pig cerebellar slices","volume":"206","author":"Okamoto","year":"1981","journal-title":"Brain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0014-2999(02)01272-4","article-title":"Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release","volume":"437","author":"Olive","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.autrev.2015.07.011","article-title":"Immunological GABAergic interactions and therapeutic applications in autoimmune diseases","volume":"14","author":"Prud'Homme","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0005-2736(00)00315-1","article-title":"Molecular characterization of taurine transport in bovine aortic endothelial cells","volume":"1509","author":"Qian","year":"2000","journal-title":"Biochimica Biophysica Acta-Biomembranes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1530-0277.2007.00569.x","article-title":"Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes","volume":"32","author":"Reilly","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s00726-014-1813-0","article-title":"Modulation of GABA-A receptors of astrocytes and STC-1 cells by taurine structural analogs","volume":"46","author":"Reyes-Haro","year":"2014","journal-title":"Amino Acids"},{"key":"B40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2165\/00003088-199835050-00001","article-title":"Clinical pharmacokinetics of acamprosate","volume":"35","author":"Saivin","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"eabn9257","DOI":"10.1126\/science.abn9257","article-title":"Taurine deficiency as a driver of aging","volume":"380","author":"Singh","year":"2023","journal-title":"Science"},{"key":"B42","first-page":"159","article-title":"Alcohol's effect on host defense","volume":"37","author":"Szabo","year":"2015","journal-title":"Alcohol Research-Current Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"130770","DOI":"10.1016\/j.foodchem.2021.130770","article-title":"Levels of taurine, hypotaurine and homotaurine, and amino acids profiles in selected commercial seaweeds, microalgae, and algae-enriched food products","volume":"368","author":"Terriente-Palacios","year":"2022","journal-title":"Food Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/biomedicines11020254","article-title":"The GABA and GABA-receptor system in inflammation, anti-tumor immune responses, and COVID-19","volume":"11","author":"Tian","year":"2023","journal-title":"Biomedicines"},{"key":"B45","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1038\/s41598-018-32733-3","article-title":"Homotaurine, a safe blood-brain barrier permeable GABAA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis","volume":"8","author":"Tian","year":"2018","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"23846","DOI":"10.1038\/s41598-021-03297-6","article-title":"Identification of fractures in tight-oil reservoirs: a case study of the Da'anzhai member in the central Sichuan Basin, SW China","volume":"11","author":"Tian","year":"2021","journal-title":"Sci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-4899-0182-8_41","article-title":"Sodium- and chloride-dependent transport of taurine at the blood-brain barrier","volume":"2","author":"Tsuji","year":"1996","journal-title":"Taurine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s11064-014-1351-x","article-title":"Modifications of diflunisal and meclofenamate carboxyl groups affect their allosteric effects on GABAA receptor ligand binding","volume":"39","author":"Uusi-Oukari","year":"2014","journal-title":"Neurochem. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"15218","DOI":"10.1073\/pnas.2435171100","article-title":"Ethanol enhances \u03b14\u03b23\u03b4 and \u03b16\u03b23\u03b4 GABAA receptors at low concentrations known to affect humans","volume":"100","author":"Wallner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0076-6879(07)28025-5","article-title":"Phenotype of the taurine transporter knockout mouse","volume":"428","author":"Warskulat","year":"2007","journal-title":"Osmosensing Osmosignaling"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e17152","DOI":"10.1371\/journal.pone.0017152","article-title":"Anaesthetic impairment of immune function is mediated via GABAA receptors","volume":"6","author":"Wheeler","year":"2011","journal-title":"Plos One"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1271203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:24:22Z","timestamp":1702574662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1271203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":51,"alternative-id":["10.3389\/fphar.2023.1271203"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1271203","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"article-number":"1271203"}}